Cells’ Response to SARS-CoV-2 Different from Flu, RSV
Cells’ Response to SARS-CoV-2 Different from Flu, RSV
The host transcriptional signature elicited by the coronavirus appears to be less robust and lacks the induction of key antiviral genes.
Cells’ Response to SARS-CoV-2 Different from Flu, RSV
Cells’ Response to SARS-CoV-2 Different from Flu, RSV

The host transcriptional signature elicited by the coronavirus appears to be less robust and lacks the induction of key antiviral genes.

The host transcriptional signature elicited by the coronavirus appears to be less robust and lacks the induction of key antiviral genes.

influenza
Coronavirus’s Genetics Reveal Its Global Travels
Coronavirus’s Genetics Reveal Its Global Travels
Ashley Yeager | Feb 25, 2020
Random mutations in the SARS-CoV-2 pathogen’s genome help researchers track the spread and transmission of COVID-19, the disease it causes.
Drug-Resistant Flu Can Emerge After Patients Take Antiviral
Drug-Resistant Flu Can Emerge After Patients Take Antiviral
Kerry Grens | Nov 26, 2019
Roughly a quarter of 38 viral samples from people treated with Xofluza had mutations in their genomes that made the pathogens less susceptible to the drug.
Keto Diet Protects Mice from Flu
Keto Diet Protects Mice from Flu
Abby Olena | Nov 15, 2019
The low-carb, high-fat diet increases the presence of gamma-delta T cells in the animals’ lungs, improving a mucus barrier against the virus.
Gut Microbes Boost Flu Vaccine’s Success: Clinical Trial
Gut Microbes Boost Flu Vaccine’s Success: Clinical Trial
Abby Olena | Sep 5, 2019
Antibiotics disrupt the immune response to the influenza vaccine in people who haven’t recently had exposure to the virus or immunization.
Image of the Day: Resilient Lung Cells
Image of the Day: Resilient Lung Cells
Nicoletta Lanese | Aug 1, 2019
A specific type of lung cell withstands flu infection by doubling down on DNA repair.
MIT Researcher Allegedly Copied Other Groups’ Drug Designs
MIT Researcher Allegedly Copied Other Groups’ Drug Designs
Catherine Offord | May 29, 2019
Executives at a biotech that develops new antibodies argue that Ram Sasisekharan didn’t come up with the structures for at least two experimental therapies that his group has described.
Climate Change May Hamper Response to Flu: Study
Climate Change May Hamper Response to Flu: Study
Carolyn Wilke | Feb 5, 2019
Mice exposed to heat wave temperatures ate less and showed weakened immune responses to the virus.
First Universal Flu Vaccine to Enter Phase 3 Trial
First Universal Flu Vaccine to Enter Phase 3 Trial
Ashley P. Taylor | Nov 12, 2018
Numerous experimental vaccines that aim to provide multi-season protection are in human studies.
Two Experimental Drugs Reduce Infections in the Elderly
Two Experimental Drugs Reduce Infections in the Elderly
Sukanya Charuchandra | Jul 12, 2018
Despite the treatment being given for only six weeks, the positive effects lasted for a year.